Deadly virus structures point toward new aven
By comparing the structures of protein complexes from different lineages of the dangerous Lassa virus, a Scripps Research team identified new antibodies and vaccine targets.
Stay updated with breaking news from Max Crispin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By comparing the structures of protein complexes from different lineages of the dangerous Lassa virus, a Scripps Research team identified new antibodies and vaccine targets.
A team led by scientists at Scripps Research and the University of Amsterdam has achieved an important goal in virology: mapping, at high resolution, critical proteins that stud the surface of the Hepatitis C virus (HCV) and enable it to enter host cells.
A team led by scientists at Scripps Research and the University of Amsterdam has achieved an important goal in virology: mapping, at high resolution, critical proteins that stud the surface of the Hepatitis C virus (HCV) and enable it to enter host cells.
The first generation of COVID-19 vaccines has been very effective; however, they do have certain limits. Their effectiveness can diminish without a booster shot, and they may be less effective against certain variants.
Microscopic images from new research have shown how the Oxford/AstraZeneca vaccine turns cells into “little factories” to fight off Covid-19. Scientists from the universities of Oxford and Southampton have examined thousands of images to compare how the protein spikes from the vaccine develop on the surface of cells. The SARS-CoV-2 virus, which causes Covid-19, has a large number of spikes sticking out of its surface that it uses to attach to, and enter, cells in the human body. These spikes are coated in sugars, known as glycans, which disguise parts of the viral proteins to the human im...